Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GPC3 Positive Hepatocellular Carcinoma”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Early research (Phase 1)Looking for participantsNCT06891742
What this trial is testing

Phase I Study of OriC902 in Treatment of Advanced HCC

Who this might be right for
HCC
Peking University 44
Testing effectiveness (Phase 2)WithdrawnNCT02723942
What this trial is testing

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Who this might be right for
GPC3 Positive Hepatocellular CarcinomaCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06641453
What this trial is testing

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Chinese PLA General Hospital 30
Not applicableLooking for participantsNCT07039201
What this trial is testing

Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University 12
Early research (Phase 1)UnknownNCT05783570
What this trial is testing

To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

Who this might be right for
Advanced Hepatocellular Carcinoma
Eutilex 12
Early research (Phase 1)Not Yet RecruitingNCT07224568
What this trial is testing

Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors

Who this might be right for
Solid Tumor (Excluding CNS)Hepatocellular CarcinomaLiver Cell Carcinoma+3 more
Seattle Children's Hospital 21
Early research (Phase 1)Looking for participantsNCT07493044
What this trial is testing

An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)GPC3 Positive Hepatocellular Carcinoma
Guangzhou FineImmune Biotechnology Co., LTD. 15
Very early researchLooking for participantsNCT06652243
What this trial is testing

Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 12
Early research (Phase 1)UnknownNCT04121273
What this trial is testing

GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120271
What this trial is testing

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

Who this might be right for
Hepatocellular CarcinomaSquamous Cell Carcinoma of the LungMerkel Cell Carcinoma+1 more
Sotio Biotech Inc. 7
Early research (Phase 1)Study completedNCT02905188
What this trial is testing

Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)

Who this might be right for
Hepatocellular Carcinoma
Baylor College of Medicine 9
Early research (Phase 1)Active Not RecruitingNCT05103631
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Who this might be right for
Liver Cell CarcinomaSolid TumorWilms Tumor+5 more
Baylor College of Medicine 12
Testing effectiveness (Phase 2)Looking for participantsNCT06427941
What this trial is testing

BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines 630
Early research (Phase 1)Looking for participantsNCT06198296
What this trial is testing

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Who this might be right for
HepatoblastomaHepatocellular CarcinomaWilms Tumor+5 more
Baylor College of Medicine 21
Very early researchUnknownNCT05070156
What this trial is testing

B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Tongji University 3
Very early researchLooking for participantsNCT07242417
What this trial is testing

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

Who this might be right for
Solid CancerGPC3 Positive Hepatocellular Carcinoma
Beijing GoBroad Hospital 30
Early research (Phase 1)Looking for participantsNCT06687941
What this trial is testing

Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell Lung+1 more
Aptamer Sciences, Inc. 70
Testing effectiveness (Phase 2)UnknownNCT03084380
What this trial is testing

Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Xinqiao Hospital of Chongqing 20